首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Comparative activities of cefuroxime amoxicillin-clavulanic acid ciprofloxacin enoxacin and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
【2h】

Comparative activities of cefuroxime amoxicillin-clavulanic acid ciprofloxacin enoxacin and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.

机译:头孢呋辛阿莫西林-克拉维酸环丙沙星依诺沙星和氧氟沙星对从咬合伤口分离的需氧和厌氧细菌的比较活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We studied the comparative in vitro activities of 10 oral antimicrobial agents against 147 aerobic and 61 anaerobic bacteria making up species in 13 genera (Staphylococcus aureus, streptococci, Eikenella corrodens, Pasteurella multocida, Haemophilus-Actinobacillus spp., M-5, EF-4, Moraxella spp., Flavobacterium IIb, Bacteroides melaninogenicus, Bacteroides spp., Fusobacterium spp., and Peptostreptococcus spp.) that were isolated from bite wounds. Cefuroxime was generally greater than fourfold more active than cephalexin and cefadroxil against all aerobic isolates, including Pasteurella multocida. The fluoroquinolones were highly active against most aerobic isolates but were less active against anaerobic isolates. Ciprofloxacin was generally more active than either enoxacin or ofloxacin. Discrepancies of greater than 30% in the interpretation of susceptibilities between break points suggested by the National Committee for Clinical Laboratory Standards and those related to oral dose peak levels (one-half to one-quarter of maximum achievable concentrations) were noted in 14% (18 of 130) of the instances.
机译:我们研究了10种口服抗菌剂对组成13个属(金黄色葡萄球菌,链球菌,艾肯氏菌,多杀巴斯德氏菌,嗜血杆菌-放线杆菌,M-5,EF-4)的147种需氧菌和61种厌氧菌的体外比较活性。从咬伤伤口中分离出来的,例如,莫拉氏菌(Moraxella spp。),黄杆菌属IIb,黑色素杆菌(Bacteroides melaninogenicus),拟杆菌(Bacteroides spp。),镰刀菌(Fusobacterium spp。)和Peptostreptocococus spp。头孢呋辛对所有有氧分离物(包括多杀巴斯德氏菌)的活性通常比头孢氨苄和头孢氨苄高四倍。氟喹诺酮类药物对大多数需氧菌具有很高的活性,而对厌氧菌则没有活性。环丙沙星通常比依诺沙星或氧氟沙星更有活性。全国临床实验室标准委员会建议的断点敏感性与口服剂量峰值水平(最大可达到浓度的二分之一到四分之一)有关的解释之间的差异大于30%(注: 130个实例中的18个)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号